Monosaccharides modulate HCV E2 protein-derived peptide biological properties

Biochemical and Biophysical Research Communications

Volumn 355, Issue 2, 2007, Pages 409-418

  Garcia, Javier E ^a,b   Fierro, Ricardo ^b   Puentes, Alvaro ^a   Cortés, Jimena ^a   Bermúdez, Adriana ^a   Cifuentes, Gladys ^a   Vanegas, Magnolia ^a   Patarroyo, Manuel E ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

HCV; HLA DR molecules; N Glycopeptide; N Glycosylation

Indexed keywords

GLYCOPEPTIDE; HLA DR ANTIGEN; IODINE 125; MONOCLONAL ANTIBODY; MONOSACCHARIDE; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CIRCULAR DICHROISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; GLYCOSYLATION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HLA SYSTEM; ISOTOPE LABELING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE SYNTHESIS; PREDICTION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VIRUS HEPATITIS;

AMINO ACID SEQUENCE; CIRCULAR DICHROISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HEPACIVIRUS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MONOSACCHARIDES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN BINDING; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 33847103746     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.167     Document Type: Article

References (19)

1. Chisari F. Unscrambling hepatitis C virus-host interactions. Nature 436 (2005) 930-932
2. Flint M., and McKeating J. The role of the hepatitis C virus glycoproteins in infection. Rev. Med. Virol. 10 (2000) 101-117
3. Lozach P.Y., Lortat-Jacob H., de Lacroix de Lavalette A., Staropoli I., Foung S., Amara S., Houles C., Fieschi F., Schwartz O., Virelizier J.L., Arenzana-Seisdedos F., and Altmeyer R. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus E2 glyco protein. J. Biol. Chem. 278 (2003) 20358-20366
4. Fournillier A., Wychowski C., Boucreux D., Baumert T., Meunier J., Jacobs D., Muguet S., Depla E., and Inchauspe G. Induction of Hepatitis C Virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites. J. Virol. 75 (2001) 12088-12097
5. Goffard A., and Dubuisson J. Glycosylation of hepatitis C virus envelope proteins. Biochimie 85 (2003) 295-301
6. Yarema K., and Bertozzi C.R. Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Curr. Opin. Chem. Biol. 2 (1998) 49-61
7. Chong P., Chan N., Kandil A., Tripet B., James O., Yang Y.P., Shi S.P., and Klein M. A strategy for ratiónal design of fully synthetic glycopeptide conjugate vaccines. Infect. Immun. 65 (1997) 4918-4925
8. Bartenschlager R., and Lohmann V. Replication of hepatitis C virus. J. Gen. virol. 81 (2000) 1631-1648
9. Choo Q.L., Richman K., Han H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medona-Selby A., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., and Houghton M. Genetic organization and diversity of the Hepatitis C virus. Proc. Natl. Acad. Sci. USA 88 (1991) 2451-2455
10. Mink M.A., Benichou S., Madaule P., Tiollais P., Prince A.M., and Inchauspe G. Characterizatión and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 200 (1994) 246-255
11. Lee J.W., Kim K., Jung S.H., Lee K.J., Choi E.C., Sung Y.C., and Kang C.Y. Identificatión of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies. J. Virol. 73 (1999) 11-18
12. Garcia J.E., Puentes A., Suarez J., Lopez R., Vera R., Rodriguez L.E., Ocampo M., Curtidor H., Guzman F., Urquiza M., and Patarroyo M.E. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J. Hepatol. 36 (2002) 254-262
13. Yagnik A.T., Lahm A., Meola A., Roccasecca R.M., Ercole B.B., Nicosia A., and Tramontano A. A model for the hepatitis C virus envelope glyco E2 protein. Proteins 40 (2000) 355-366
14. Slater-handshy T., Droll D., Fan X., Bisceglie A., and Chambers T.J. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing. Virology 319 (2004) 36-48
15. Garcia J.E., Puentes A., Curtidor H., Vera R., Rodriguez L.E., Valbuena J., Lopez R., Ocampo M., Cortes J., Vanegas M., Rosas J.E., Reyes C., and Patarroyo M.E. Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells. Peptides 26 (2005) 1133-1143
16. Vargas L.E., Parra C.A., Salazar L.M., Guzman F., Pinto M., and Patarroyo M.E. MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6. Biochem. Biophys. Res. Commun. 307 (2003) 148-156
17. Fanning L.J., Levis J., Kenny-Walsh E., Wynne F., Whelton M., and Shanahan F. Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen Class II in a homogeneous population. Hepatology 31 (2000) 1334-1337
18. Eckels D.D., Wang H., Bian T.H., Tabatabai N., and Gill J.C. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV. Infect. Immunol. Rev. 174 (2000) 90-97
19. Percze1 A., Hollbsi M., Foxman B.M., and Fasman G.D. Conformational analysis of pseudocyclic hexapeptides based on quantitative circular dichroism (CD), NOE, and X-ray data. The pure CD spectra of type i and type I1 β-turns. J. Am. Chem. Soc. 113 (1991) 9184-9772